Skip to content

Evoke and Evoke+ Ozempic Drug Trials fail to live up to Dementia promise

Over the last few years, drugs like Ozempic have gained a strong reputation for helping with more than just diabetes and weight loss. These medicines, known as GLP-1 agonists, have shown promise in improving liver, kidney, and heart... (Audio Available – 438 words – 2 minute read time)

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

Piezo1 protein in the cells lining brain blood vessels disrupts normal circulation

A recent study has uncovered a way to fix faulty blood flow in the brain, which could play a key role in tackling dementia symptoms. Researchers found that an overactive protein called Piezo1 in the cells lining brain blood vessels disrupts... (Audio available – 445 words – 2 minute read time)

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

Scientists Reverse Advanced Alzheimer’s in Mice and Restore Memory

New research is challenging that long held belief, offering a message of real hope. Scientists have shown that by fixing a fundamental problem in the brain’s energy supply, it is possible not just to slow or prevent... (Audio available – 660 words – 3 minute read time)

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

New Early Prevention Drug, meet NU-9

New research from Northwestern University in the USA suggests dementia begins quietly, often many years - even decades - before any obvious memory loss shows up. The key problem seems to be tiny, harmful clumps of a protein called... (Audio available – 465 words – 2 minute read time)

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

Breakthrough Drug NU-9 Stops Alzheimer’s in Mice Before Signs Show Up

A fresh study from Northwestern University brings new hope in the fight against Alzheimer's disease, showing that an experimental drug called NU-9 can halt early brain changes in mice before any symptoms appear. This work uncovers a hidden trigger... (Audio Available – 801 words – 4 minute read time)

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here